Kirsch, B., J. DuBois, and D. Chadha. “A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, With Axillary Hyperhidrosis”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S54, doi:10.25251/skin.3.supp.54.